Snapshots of a hybrid transcription factor in the Hippo pathway
- PMID: 21203923
- PMCID: PMC4875227
- DOI: 10.1007/s13238-010-0105-z
Snapshots of a hybrid transcription factor in the Hippo pathway
Abstract
The Hippo pathway plays key roles in animal development. It suppresses tumorigenesis by controlling the transcription of the target genes that are critical for cell proliferation and apoptosis. The transcriptional coactivator YAP is the major downstream effector of the Hippo signaling. Upon extracellular stimulation, a kinase cascade in the Hippo pathway phosphorylates YAP and promotes its cytoplasmic sequestration by 14-3-3 and ubiquitin-dependent degradation. When the Hippo pathway is turned off, YAP (which lacks a DNA-binding domain) is dephosphorylated and translocates to the nucleus, where it associates with the transcription factor TEAD to form a functional heterodimeric transcription factor and to promote the expression of the Hippo-responsive genes. Recently, structures of the YAP-binding domain of TEAD alone or in complex with YAP have revealed the atomic details of the TEAD-YAP interaction. Here, I review these exciting advances, propose a strategy for targeting the TEAD-YAP interaction using small molecules, and suggest potential mechanisms by which phosphorylation and 14-3-3 binding regulate the cytoplasmic retention of YAP.
Similar articles
-
Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control.Genes Dev. 2007 Nov 1;21(21):2747-61. doi: 10.1101/gad.1602907. Genes Dev. 2007. PMID: 17974916 Free PMC article.
-
Molecular mechanisms of the mammalian Hippo signaling pathway.Yi Chuan. 2017 Jul 20;39(7):546-567. doi: 10.16288/j.yczz.17-094. Yi Chuan. 2017. PMID: 28757470 Review.
-
Yorkie and Scalloped: partners in growth activation.Dev Cell. 2008 Mar;14(3):315-6. doi: 10.1016/j.devcel.2008.02.010. Dev Cell. 2008. PMID: 18331708
-
The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version.Genes Dev. 2010 May;24(9):862-74. doi: 10.1101/gad.1909210. Genes Dev. 2010. PMID: 20439427 Free PMC article.
-
The role of extracellular biophysical cues in modulating the Hippo-YAP pathway.BMB Rep. 2017 Feb;50(2):71-78. doi: 10.5483/bmbrep.2017.50.2.199. BMB Rep. 2017. PMID: 27916025 Free PMC article. Review.
Cited by
-
STK25 suppresses Hippo signaling by regulating SAV1-STRIPAK antagonism.Elife. 2020 Apr 15;9:e54863. doi: 10.7554/eLife.54863. Elife. 2020. PMID: 32292165 Free PMC article.
-
The hippo-yes association protein pathway in liver cancer.Gastroenterol Res Pract. 2013;2013:187070. doi: 10.1155/2013/187070. Epub 2013 Aug 6. Gastroenterol Res Pract. 2013. PMID: 23986776 Free PMC article.
-
Structural basis for autoactivation of human Mst2 kinase and its regulation by RASSF5.Structure. 2013 Oct 8;21(10):1757-68. doi: 10.1016/j.str.2013.07.008. Epub 2013 Aug 22. Structure. 2013. PMID: 23972470 Free PMC article.
-
SAV1 promotes Hippo kinase activation through antagonizing the PP2A phosphatase STRIPAK.Elife. 2017 Oct 24;6:e30278. doi: 10.7554/eLife.30278. Elife. 2017. PMID: 29063833 Free PMC article.
-
Regulatory mechanisms of the Hippo/YAP axis by G-protein coupled estrogen receptor in gastric signet-ring cell carcinoma.Neoplasia. 2025 Sep;67:101199. doi: 10.1016/j.neo.2025.101199. Epub 2025 Jun 23. Neoplasia. 2025. PMID: 40554953 Free PMC article.
References
-
- Alarcón C., Zaromytidou A.I., Xi Q., Gao S., Yu J., Fujisawa S., Barlas A., Miller A.N., Manova-Todorova K., Macias M.J., et al. Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-beta pathways. Cell. 2009;139:757–769. doi: 10.1016/j.cell.2009.09.035. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources